Healthcare at Home: CMC Dubai’s Innovative Program

By Crystal Lubbe

February 12, 2025

Healthcare at Home

Imagine receiving hospital-level care without ever stepping into a hospital. CMC Dubai, in collaboration with Forevue Health Managed Care Network, has introduced the “Healthcare at Home” program. This innovative initiative uses wearable monitoring technology to offer continuous medical care to individuals with chronic illnesses, all from the comfort of their homes. The program aims to reduce hospital stays by 70% and healthcare costs by over 30%, while improving patient outcomes through personalised care. The focus on home healthcare highlights a commitment to raising care standards and enhancing accessibility.

Transformative Healthcare Program Overview

This new healthcare program promises to change patient care by significantly reducing hospital stays and cutting healthcare costs. The initiative uses advanced monitoring technology, equipping patients with wearable devices that track vital health indicators like stress levels, blood pressure, heart rate, blood sugar, and sleep patterns. This data is sent in real-time to a state-of-the-art operations center at CMC Hospital Dubai, allowing for 24/7 monitoring and quick response. The program targets chronic diseases such as diabetes, hypertension, and heart disease. By providing hospital-level care without frequent hospital visits, it eases the burden on families and insurers.

The “Healthcare at Home” concept

  • CMS Acute Hospital Care at Home (HAH) Program: In the U.S., the Centers for Medicare & Medicaid Services (CMS) developed the HAH program, enabling hospitals to offer inpatient-level care at home. This initiative has led to lower mortality rates, fewer complications, and higher patient satisfaction compared to traditional hospital care.

  • Clinical Outcomes and Cost Savings: Studies show that hospital-at-home programs can improve patient outcomes, reduce hospital readmissions, and achieve significant cost savings.

Health Economics

The implementation of programs that decrease the need for hospital stays and frequent assessments plays a crucial role in significantly lowering healthcare costs for both patients and insurers. In Dubai, these cost reductions, particularly in chronic care management, can enhance the long-term sustainability of the healthcare and insurance sectors. By minimising the financial burden associated with prolonged hospitalisations and repetitive medical evaluations, such programs contribute to a more financially viable healthcare system.

Improved Patient Care

Continuous monitoring and proactive interventions are key components of these programs, leading to better management of chronic conditions. This approach helps minimise complications and improves overall health outcomes for patients. By addressing health issues promptly and effectively, patients experience a higher quality of care, which is essential for managing long-term health conditions.

Patient Satisfaction

Programs like Healthcare at Home significantly enhance patient satisfaction by allowing individuals to receive care in the comfort of their own environment. This personalised approach not only improves the patient experience but also fosters a sense of autonomy and convenience, which are important factors for patient contentment and adherence to treatment plans.

Insurance Ecosystem

The initiative has the potential to positively influence the insurance ecosystem by reducing costs associated with frequent assessments. By lowering these expenses, insurance companies can avoid passing on high costs to consumers through increased premiums, thus maintaining more affordable insurance options for the public.

Healthcare System Efficiency

By alleviating the pressure on hospitals, these programs contribute to improved efficiency within the healthcare system. With fewer patients requiring inpatient care, hospitals can allocate resources more effectively, ensuring that critical and emergency services are available to those who need them most. This streamlined approach enhances the overall functionality and responsiveness of the healthcare system, benefiting both providers and patients alike.

Reference url

Recent Posts

EMA CHMP Meeting Highlights
Regulatory Insights from EMA CHMP Meeting Highlights

By HEOR Staff Writer

June 26, 2026

The EMA CHMP Meeting Highlights from 22-25 June 2026 show the committee advancing six new medicines while maintaining rigorous evidentiary standards for complex and rare conditions. Positive opinions covered an inactivated influenza vaccine for adults 50 and older, a levodopa-carbidopa intestinal...
KEYTRUDA combination therapy
KEYTRUDA Combination Therapy Gains FDA Approval for Advanced Triple-Negative Breast Cancer

By João L. Carapinha

June 26, 2026

The FDA has approved KEYTRUDA combination therapy with Trodelvy as first-line treatment for adults with unresectable locally advanced or metastatic triple-negative breast cancer whose tumors express PD-L1 at a Combined Positive Score of 10 or greater. This marks the first regulatory nod for a PD-...
calcified carotid lesion preparation
Innovations in Calcified Carotid Lesion Preparation for Enhanced Stroke Management

By João L. Carapinha

June 26, 2026

Johnson & Johnson has begun enrolling patients in the SKYWARD clinical program, advancing calcified carotid lesion preparation with a purpose-built intravascular lithotripsy platform that fractures hardened plaque to improve stent deployment. This first-of-its-kind